학술논문
MEsenchymal StEm cells for Multiple Sclerosis (MESEMS): A randomized, double blind, cross-over phase I/II clinical trial with autologous mesenchymal stem cells for the therapy of multiple sclerosis
Document Type
Article
Author
Uccelli, A.; Laroni, A.; Brundin, L.; Clanet, M.; Fernandez, O.; Nabavi, S.M.; Muraro, P.A.; Oliveri, R.S.; Radue, E.W.; Wuerfel, J.T.; Sellner, J.; Soelberg Sorensen, P.; Sormani, M.P.; Battaglia, M.A.; Freedman, M.S.; Bonetti, B.; Rush, C.; Herrera, C.; Ramo Tello, C.; Miller, D.; Szwajcer, D.; Strunk, D.; Wall, D.; Aguera-Morales, E.; Rohde, E.; Dazzi, F.; Comi, G.; Martino, G.; Izquierdo Ayuso, G.; Rabinovitch, H.; MacLean, H.; Marriott, J.; Racosta, J.; Arab, L.; Gimona, M.; Introna, M.; Blinkenberg, M.; Aghdami, N.; Ali, R.; Vosoughi, R.; Nicholas, R.; Marrie, R.A.; Karimi, S.
Source
In: Trials . (Trials, 9 May 2019, 20(1))
Subject
Language
English
ISSN
17456215